Article Details
Retrieved on: 2021-06-21 15:22:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
As things stand now, the biopharma's shares are probably trading at around three times 2022 sales. That's a fairly typical valuation for a healthcare ...
Article found on: www.fool.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here